High-dose Ara-C as a single-agent consolidation therapy in childhood acute myelogenous leukemia

Haematol Blood Transfus. 1990:33:215-21. doi: 10.1007/978-3-642-74643-7_39.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow Transplantation
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Cross-Sectional Studies
  • Cytarabine / administration & dosage*
  • Down Syndrome / complications
  • Doxorubicin / administration & dosage
  • Humans
  • Iceland / epidemiology
  • Infant
  • Infant, Newborn
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / surgery
  • Leukemia, Myelomonocytic, Acute / drug therapy*
  • Leukemia, Myelomonocytic, Acute / mortality
  • Leukemia, Myelomonocytic, Acute / surgery
  • Life Tables
  • Multicenter Studies as Topic
  • Preleukemia / epidemiology
  • Remission Induction
  • Scandinavian and Nordic Countries / epidemiology
  • Survival Rate
  • Thioguanine / administration & dosage

Substances

  • Cytarabine
  • Doxorubicin
  • Thioguanine